Patents by Inventor Jacques Bouvier

Jacques Bouvier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190380981
    Abstract: The present invention concerns the use of lufenuron for controlling sea lice in a fish population, which comprises feeding lufenuron to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: August 30, 2019
    Publication date: December 19, 2019
    Inventors: David Blaser, Jacques Bouvier, Martin Fink, John Gerard McHenery, Steve Nanchen
  • Publication number: 20150272931
    Abstract: The present invention concerns the use of clothianidin for controlling sea lice in a fish population, which comprises feeding clothianid to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: October 24, 2013
    Publication date: October 1, 2015
    Inventors: Jacques BOUVIER, Steve NANCHEN, Jean-Luc PERRET
  • Publication number: 20150125509
    Abstract: The present invention concerns the use of lufenuron for controlling sea lice in a fish population, which comprises feeding lufenuron to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: May 8, 2013
    Publication date: May 7, 2015
    Inventors: David Blaser, Jacques Bouvier, Martin Fink, John Gerard Mchenery, Steve Nanchen
  • Patent number: 8940782
    Abstract: The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) as described herein. Further, the present invention is directed to corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin.
    Type: Grant
    Filed: November 16, 2012
    Date of Patent: January 27, 2015
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Tania Cavaliero, Maike Renner, Jacques Bouvier
  • Publication number: 20130143924
    Abstract: The present invention is directed to a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I) as described herein. Further, the present invention is directed to corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin.
    Type: Application
    Filed: November 16, 2012
    Publication date: June 6, 2013
    Inventors: Pierre DUCRAY, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
  • Patent number: 8367682
    Abstract: The invention relates to new pyrimidine compounds of formula (1) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (1) are useful in the control of parasites, in particular ectoparasites, in and on warmblooded animals.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: February 5, 2013
    Assignee: Novartis AG
    Inventors: Noëlle Gauvry, François Pautrat, Jacques Bouvier, Jörg Früchtel, Beatrice Bapst, Sandra Schorderet Weber
  • Patent number: 8338490
    Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: December 25, 2012
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
  • Patent number: 8128943
    Abstract: The present invention relates to the use of compounds of formula (I), wherein R1, X, Y, Z and m are as defined in the description, in the free form or in salt form either alone or in combination with a vaccine component, for controlling fish parasites, in particular sea lice.
    Type: Grant
    Filed: August 28, 2006
    Date of Patent: March 6, 2012
    Assignee: Novartis AG
    Inventors: Jacques Bouvier, John Marshall, Richard Hunter
  • Publication number: 20110021543
    Abstract: Novel N-aryl substituted heteroindole compounds, processes for their manufacture, veterinary compositions containing such compounds, and methods of controlling ectoparasites are provided. The compounds are believed effective in the control of ectoparasites on warm-blooded productive livestock and domestic animals.
    Type: Application
    Filed: April 29, 2008
    Publication date: January 27, 2011
    Inventors: Noelle Gauvry, Jorg Fruchtel, Thomas Goebel, Sandra Schorderet Weber, Jacques Bouvier
  • Publication number: 20100303865
    Abstract: The present invention relates to the use of compounds of formula (I), wherein R1, X, Y, Z and m are as defined in the description, in the free form or in salt form either alone or in combination with a vaccine component, for controlling fish parasites, in particular sea lice.
    Type: Application
    Filed: August 28, 2006
    Publication date: December 2, 2010
    Applicants: NOVARTIS AG, NOVARTIS PHARMA GMBH
    Inventors: Jacques Bouvier, John Marshall, Richard Hunter
  • Patent number: 7749526
    Abstract: Compounds of formula (I) are described for deterring vermin, wherein R is unbranched or branched C1-C15 alkyl, which is unsubstituted or substituted by halogen, cyano or nitro; R1 and R2 are unbranched or branched C1-C12 alkyl, preferably C1-C6 alkyl, which is unsubstituted or substituted by halogen, cyano or nitro; and X and Y, independently of one another, are a straightchain or branched alkylene bridge with 1 to 20 carbon atoms, preferably an alkylene bridge with 1 to 3 carbon atoms, which is unsubstituted or substituted by halogen, cyano or nitro. Furthermore, an essentially non-therapeutical process for deterring vermin is described, which is based on the usage of these compounds, as well as verminrepellent compositions containing these compounds as the active ingredient, and finally the use of these compounds for producing vermin-deterring compositions and their usage in deterring vermin from animals, humans and objects. New compounds within the scope of formula (I) are also described.
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: July 6, 2010
    Assignee: Novartis AG
    Inventors: Thomas Goebel, Tania Cavaliero, Jacques Bouvier
  • Patent number: 7705044
    Abstract: The invention relates to compounds of the general formula and optionally the enantiomers thereof. These compounds have advantageous pesticidal properties. They are especially suitable for controlling parasites in warm-blooded animals.
    Type: Grant
    Filed: May 14, 2002
    Date of Patent: April 27, 2010
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Jacques Bouvier, Matthias Keller, Corina Bergamin
  • Patent number: 7700656
    Abstract: The invention relates to the use of aminoacetonitrile compounds of formula (I), wherein R1, R2, R3, R4, R8, R9, A, m and n have the significances given in claim 1, in the control of endoparasites, especially helminths, in warm-blooded productie livestock and domestic animals.
    Type: Grant
    Filed: December 18, 2001
    Date of Patent: April 20, 2010
    Assignee: Novartis AG
    Inventors: Pierre Ducray, Jacques Bouvier
  • Publication number: 20100063090
    Abstract: The invention describes essentially a non-therapeutical process for deterring vermin, which is based on the usage of the largely known beta amino-alcohol derivatives of formula (I), as defined herein before. Furthermore, it describes the corresponding vermin-deterring compositions which contain these substances as the active ingredient, compounds of the formula (I) for the preparation of vermin-deterring compositions, and the use of compounds of formula (I) in the defense against vermin. Thus, the invention describes how and in which form the compounds of the formula (I) or their acid addition salts are used to deter vermin from materials, places or warm-blooded animals.
    Type: Application
    Filed: November 21, 2007
    Publication date: March 11, 2010
    Applicant: Novartis AG
    Inventors: Pierre Ducray, Tania Cavaliero, Maike Lohrmann, Jacques Bouvier
  • Publication number: 20100010003
    Abstract: The invention relates to new pyrimidine compounds of formula (1) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (1) are useful in the control of parasites, in particular ectoparasites, in and on warmblooded animals.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 14, 2010
    Inventors: Noelle Gauvry, Francois Pautrat, Jacques Bouvier, Jorg Fruchtel, Beatrice Bapst, Sandra Schorderet Weber
  • Publication number: 20090227538
    Abstract: The invention relates to compounds of the general formula (I) wherein R1, R2, R3, R4, R5, R6, A, X, m and n have the significances given in claim 1, and optionally the enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals and plants.
    Type: Application
    Filed: November 2, 2006
    Publication date: September 10, 2009
    Inventors: Jörg Früchtel, Noëlle Gauvry, Sandra Schorderet Weber, Jacques Bouvier
  • Publication number: 20090197902
    Abstract: The invention relates to the use of compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, X1 and X2 have the significances given in claim 1, and optionally the enantiomers and geometrical isomers thereof, for controlling parasites on warm-blooded animals.
    Type: Application
    Filed: February 27, 2009
    Publication date: August 6, 2009
    Applicants: Novartis AG, Novartis Pharma GmBH
    Inventors: Jorg Fruchtel, Noelle Gauvry, Sandra Schorderet-Weber, Tania Cavaliero, Jacques Bouvier, Francois Pautrat
  • Patent number: 7446219
    Abstract: The invention relates to compounds of the general formula in which R1, R2, R3, R4, R5, R6, W, X, A1, A2, a, b and c are as defined in the specification, and to any enantiomers thereof. The active ingredients have advantageous pesticidal properties. They are particularly suitable for controlling parasites in warm-blooded animals.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: November 4, 2008
    Assignee: Novartis Animal Health US Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jacques Bouvier, Corinne Durano
  • Patent number: 7304018
    Abstract: The invention relates to compounds of the general formula: (I) and optionally the enantiomers thereof. The active ingredients have advantages pesticidal properties. They are especially suitable for controlling parasites on warm-blooded animals.
    Type: Grant
    Filed: June 15, 2003
    Date of Patent: December 4, 2007
    Assignee: Novartis Animal Health US, Inc.
    Inventors: Pierre Ducray, Thomas Goebel, Jacques Bouvier
  • Publication number: 20070155757
    Abstract: The invention relates to the use of compounds of the general formula (I), wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, X1 and X2 have the significances given in claim 1, and optionally the enantiomers and geometrical isomers thereof, for controlling parasites on warm-blooded animals.
    Type: Application
    Filed: March 7, 2005
    Publication date: July 5, 2007
    Inventors: Jorg Fruchtel, Noelle Gauvry, Sandra Schorderet-Weber, Tania Cavaliero, Jacques Bouvier, Francois Pautrat